The perioperative charge equivalence of radical prostatectomy with 1-year follow up since the diagnosis of prostate cancer

Acta Urologica Japonica

Volumn 50, Issue 2, 2004, Pages 71-75

  Namiki, Shunichi ^a   Ito, Akihiro ^a   Ishidoya, Shigeto ^a   Satoh, Makoto ^a   Saito, Seiichi ^a   Arai, Yoichi ^a   Tochigi, Tatsuo ^b   Kuwahara, Masaaki ^b   Ioritani, Naomasa ^c   Koinuma, Nobuo ^d  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyagi Cancer Center Hospital   (Japan)

^c Sendai Shakaihoken Hospital   (Japan)

^d Dept of Hlth Admin and Policy ^*

Author keywords

Clinical care path; Cost; Fees and charges; Prostate cancer; Prostatectomy

Indexed keywords

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIAGNOSTIC TEST; DISEASE MARKER; FOLLOW UP; HEALTH CARE FINANCING; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; OUTPATIENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSTATE CARCINOMA; PROSTATECTOMY;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; COST SAVINGS; COSTS AND COST ANALYSIS; CRITICAL PATHWAYS; HEALTH RESOURCES; HOSPITAL CHARGES; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 11144356051     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arai Y, Egawa S, Tobisu K, et al.: Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan. BJU Int 85: 287-294, 2000
2. Penson DF, Schonfeeld WH, Flanders SC, et al.: Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CaPSURE database. Urology 57: 499-503, 2001
3. Scott WW and Boyd H: Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experiene. J Urol 101: 86-92, 1969
4. Soloway MS, Sharifi R, Wajsman Z, et al.: Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. J Urol 154: 424-428, 1995
5. Klotz LH, Goldenberg SL, Jewett M, et al.: CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Urology 53: 757-763, 1999
6. Schulman CC: Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review. Prostate suppl 5: 9-14, 1994
7. Macfarlane MT, Abi-Aad A, Stein A, et al.: Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol 150: 132-134, 1993
8. Litwin MS, Smith RB, Thind A, et al.: Cost-efficient radical prostatectomy with a clinical care path. J Urol 155: 989-993, 1996
9. Litwin MS, Shpall AI and Dorey F: Patient satisfaction with short stays for radical prostatectomy. Urology 49: 898-906, 1997
10. Arai Y, Okubo K, Aoki Y, et al.: Patient-reported quality of life after radical prostatectomy. Int J Urol 6: 78-86, 1999
11. Namiki S, Tochigi T, Kuwahara M, et al.: Health related quality of life after radical prostatectomy in Japanese men with localized prostate cancer. Int J Urol 10: 643-650, 2003